FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study. (Q53550371)
Jump to navigation
Jump to search
scientific article published on 6 March 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study. |
scientific article published on 6 March 2015 |
Statements
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study (English)
Claudio Verusio
Sandro Barni
Luca Rubino
Silvia Bozzarelli
Eugenio Villa
Carlo Carnaghi
Maria Chiara Tronconi
Chiara Gerardi
Francesca Galli
Irene Floriani
Annarita Destro
Carlotta Raschioni